Filing Details
- Accession Number:
- 0000950156-14-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-06 18:34:51
- Reporting Period:
- 2014-08-04
- Filing Date:
- 2014-08-06
- Accepted Time:
- 2014-08-06 18:34:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
352998 | Igi Laboratories Inc | IG | Biological Products, (No Disgnostic Substances) (2836) | 010355758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1555152 | Jason Grenfell-Gardner | C/O Igi Laboratories, Inc, 105 Lincoln Avenue Buena NJ 08310 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-08-04 | 66,828 | $5.85 | 271,672 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2014 for the purpose of payment by the Reporting Person of tax obligations arising out of the vesting of restricted stock.
- $5.8463 is the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.6625 to $6.01. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.